Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan vs valsartan after AF ablation
jRCT1061230045Recruiting
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sacubitril + valsartan and valsartan in Atrial fibrillation (AFib) and hypertension (HTN) (2 arms). Primary endpoint: Atrial fibrillation recurrence at 12 months. Started Feb 2024; status: recruiting.
02
Drugs
sacubitril + valsartanvalsartan
03
Conditions
Atrial fibrillation (AFib)hypertension (HTN)
Beyond the preview
Go deeper on jRCT1061230045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061230045.